Failure of pre-exposure prophylaxis with on-demand tenofovir disoproxil fumarate/emtricitabine resulting in emergence of antiretroviral resistance

被引：0
|
作者：
Hsiao, Yu-Yu [1 ]
Huang, Yi-Chia [2 ]
Chang, Sui-Yuan [3 ,4 ,5 ]
Kuo, Ching-Hua [6 ]
Chang, Shu-Fang [3 ]
Lin, Ya-Ting [6 ]
Luo, Yu-Zhen [7 ]
Lee, Yu-Lin [1 ]
Hung, Chien-Ching [5 ,8 ,9 ]
机构：
[1] Changhua Christian Hosp, Dept Internal Med, 135 Nanxiao St, Changhua 50006, Taiwan
[2] Natl Taiwan Univ Hosp Biomed Pk, Dept Internal Med, Hsinchu, Taiwan
[3] Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei, Taiwan
[4] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan
[5] Natl Taiwan Univ, Coll Med, Taipei, Taiwan
[6] Natl Taiwan Univ, Sch Pharm, Taipei, Taiwan
[7] Natl Taiwan Univ Hosp, Ctr Infect Control, Taipei, Taiwan
[8] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan
[9] Natl Taiwan Univ Hosp, Dept Trop Med & Parasitol, Taipei, Taiwan
来源：
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION | 2021年 / 54卷 / 04期
关键词：
HIV infection; Nucleic-acid amplification test; Resistance-associated mutation; Combination antiretroviral therapy;
D O I：
10.1016/j.jmii.2021.01.011
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：755 / 757
页数：3
相关论文
共 50 条
  • [31] Design and evaluation of mucoadhesive vaginal tablets of tenofovir disoproxil fumarate for pre-exposure prophylaxis of HIV
    Khan, Arshad Bashir
    Thakur, Ram Sharnagat
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2018, 44 (03) : 472 - 483
  • [32] Pharmacokinetics of tenofovir disoproxyl fumarate/emtricitabine in a client on pre-exposure prophylaxis after a total gastrectomy
    Roelofsen, Eveline E.
    Wildenbeest, Sieds
    Mollema, Femke P.
    Burger, David M.
    AIDS, 2020, 34 (13) : 1989 - 1991
  • [33] Model-informed intermittent tenofovir disoproxil fumarate and emtricitabine dosing for HIV pre-exposure prophylaxis in subjects with renal impairment: a case report
    Zino, Leena
    Jacobs, Tom G.
    Nieuwenstein, Thomas
    Grintjes, Karin
    Colbers, Angela
    Burger, David M.
    AIDS, 2023, 37 (02) : 363 - 365
  • [34] Pre-exposure prophylaxis for HIV with oral tenofovir disoproxil fumarate/emtricitabine in men who have sex with men: Slovenian national demonstration project
    Pecavar, Blaz
    Kokosar Ulcar, Barbara
    Kordis, Manja
    Plesko, Maja
    Turel, Gabriele
    Vovko, Tomaz
    Tomazic, Janez
    INTERNATIONAL JOURNAL OF STD & AIDS, 2021, 32 (11) : 1060 - 1065
  • [35] Trends in the use of oral emtricitabine/tenofovir disoproxil fumarate for pre-exposure prophylaxis against HIV infection, United States, 2012-2017
    Sullivan, Patrick S.
    Giler, Robertino Mera
    Mouhanna, Farah
    Pembleton, Elizabeth S.
    Jones, Jeb
    Castel, Amanda D.
    Yeung, Howa
    Kramer, Michael
    McCallister, Scott
    Siegler, Aaron J.
    ANNALS OF EPIDEMIOLOGY, 2018, 28 (12) : 833 - 840
  • [36] Failure of pre-exposure prophylaxis with daily tenofovir/emtricitabine and the scenario of delayed HIV seroconversion
    Lee, Shui-Shan
    Anderson, Peter L.
    Kwan, Tsz-Ho
    Lui, Grace C. Y.
    Chan, Denise P. C.
    Wong, Ngai-Sze
    Lee, Krystal C. K.
    Lam, Teddy T. N.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 94 : 41 - 43
  • [37] Pill related oesophagitis due to tenofovir disproxil fumarate/emtricitabine (Truvada) HIV pre-exposure prophylaxis
    Bonnichsen, Mark H.
    Tschuchnigg, Mark
    Post, Jeffrey J.
    Bye, William
    INTERNAL MEDICINE JOURNAL, 2022, 52 (06) : 1099 - 1100
  • [38] Longer term safety of emtricitabine/tenofovir alafenamide (F/TAF) and emtricitabine/tenofovir disoproxil fumarate (F/TDF) for HIV pre-exposure prophylaxis (PrEP): DISCOVER trial week 96 results
    Ogbuagu, O.
    Podzamczer, D.
    Salazar, L.
    Henry, K.
    Asmuth, D.
    Wohl, D.
    Gilson, R.
    Shao, Y.
    Ebrahimi, R.
    Carter, C.
    Das, M.
    McCallister, S.
    Brunetta, J.
    Kronborg, G.
    Reeves, I.
    Spinner, C.
    HIV MEDICINE, 2020, 21 : 12 - 12
  • [39] On-demand pre-exposure prophylaxis with tenofovir disoproxil fumarate plus emtricitabine among men who have sex with men with less frequent sexual intercourse: a post-hoc analysis of the ANRS IPERGAY trial
    Antoni, Guillemette
    Tremblay, Cecile
    Delaugerre, Constance
    Charreau, Isabelle
    Cua, Eric
    Castro, Daniela Rojas
    Raffi, Francois
    Chas, Julie
    Huleux, Thomas
    Spire, Bruno
    Capitant, Catherine
    Cotte, Laurent
    Meyer, Laurence
    Molina, Jean-Michel
    Meyer, L.
    Capitant, C.
    Charreau, I.
    Netzer, E.
    Leturque, N.
    Binesse, J.
    Foubert, V.
    Saouzanet, M.
    Euphrasie, F.
    Carette, D.
    Guillon, B.
    Saidi, Y.
    Aboulker, J. P.
    Spire, B.
    Suzan, M.
    Cattin, G.
    Demoulin, B.
    Sagaon-Teyssier, L.
    Lorente, N.
    Dore, V.
    Choucair, E.
    Le Mestre, S.
    Mennecier, A.
    Etien, N.
    Simon, M. C.
    Diallo, A.
    Gibowski, S.
    Delfraissy, J. F.
    Thompson, D.
    Sas, J.
    Pankovitch, J.
    Klein, M.
    Anis, A.
    Molina, J-M
    Wainberg, M. A.
    Trottier, B.
    LANCET HIV, 2020, 7 (02): : E113 - E120
  • [40] Tenofovir Disoproxil Fumarate/Emtricitabine Prophylaxis Has No Effect on Bone Mineral Density and Bone Mineral Content in African Breastfeeding Women Receiving Pre-Exposure Prophylaxis for HIV
    Kistan, Gaysheen
    Sebitloane, Motshedisi
    Lombard, Carl
    Godlwana, Zukiswa
    Desmond, Alicia C.
    Clark, Richard
    Rooney, James F.
    Gray, Glenda
    Moodley, Dhayendre
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2025, 98 (03) : 265 - 273
12345